Hepatitis A virus receptor (HAVcr-1) and T-cell immunoglobulin-and mucin-domain-containing molecule (TIM)-3 were recently implicated as asthma susceptibility genes in the study of congenic mice. In a genome-wide screen, we found strong evidence for linkage of atopic asthma with marker D5S820, located approximately 0.5 Mb from hHAVcr-1 and human TIM3. We screened for mutations in human HAVcr-1 (hHAVcr-1) and in TIM3 and found seven, including two insertion/deletion polymorphisms, in hHAVcr-1 and two in TIM3. We conducted transmission disequilibrium tests (TDTs) in families identified through children with atopic asthma. None of the hHAVcr-1 allele were transmitted preferentially to asthma-affected children (P40.1). In quantitative TDT analysis, no association was observed between the log[total IgE] and either allele of the hHAVcr-1 polymorphism (P40.1). The two TIM3 mutations were rare in the Japanese population, occurring in only one of 48 unrelated asthmatic subjects. Our results indicate that hHAVcr-1 polymorphisms are not likely to be associated with the development of atopyrelated phenotypes in the Japanese population.
Introduction
Atopic diseases such as asthma, atopic eczema, and allergic rhinitis are the major causes of morbidity in developed countries and have been increasing in frequency.
1,2 Asthma is a complex disorder involving genetic and environmental factors, and several asthma susceptibility loci have been identified through genomewide screens. [3] [4] [5] [6] [7] [8] [9] In our genome-wide search for loci associated with mite-sensitive atopic asthma, we found strong evidence for linkage of marker D5S820 to atopic asthma, with a maximum lod score of 4.73. 9 Recently, McIntire et al 10 reported that TIM1, a mouse homolog of human hepatitis A virus receptor (hHAVcr-1), and TIM3 are associated with T helper type 1 (Th-1) and Th-2 differentiation and airway hyperresponsiveness in mice, and suggested that TIM plays an important role in the regulation of asthma and allergic diseases. hHAVcr-1 and TIM3 are located approximately 0.5 Mb from marker D5S820. In the present study, we screened for mutations in the promoter and coding regions of the hHAVcr-1 gene and determined genotypes of members of Japanese families identified through pediatric asthma patients.
Probands were asthmatic children who visited the Pediatric Allergy Clinic of the University Hospital of Tsukuba (Japan). A total of 144 families (476 individuals) gave informed consent and participated in the study. Criteria used for the diagnosis of asthma were as described previously.
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All exons, exon-intron junctions, and 1185 bp of the 5 0 flanking region upstream of the transcription initiation site of hHAVcr-1 were amplified by PCR and subjected to direct sequencing. PCR was also performed to amplify all exons, exon-intron junctions, and 552 bp of the 5'flanking region upstream of the transcription initiation site of TIM3, and amplified PCR products were subjected to sequencing. Primers were designed according to the published sequence of hHAVcr-1 and TIM3 (GenBank Accession Numbers AC026777 and NM_012206 for hHAVcr-1, and AC011377 and NM 032782 for TIM3). Genomic DNAs from 24 or 48 unrelated asthmatics were used for mutation screening.
We identified seven polymorphisms in the hHAVcr-1 gene: À1634A/G: À1606A/C; À1547G/C; À1453G/A; [c469-470insCAATGACAACGACTGTTC; c589-590delGTG], which we designated hHAVcr-1*allele2; c469-470in-sTGACGACTGTTCCA. which we designated hHAVcr-1*allele3; and IVS8+9G/A. We found two rare variants (c.129C4T and Tyr82Cys) in the TIM3 gene, which occurred in only one of the 48 asthmatic subjects. We determined the genotypes of these polymorphisms by restriction fragment length polymorphism (RFLP) or direct sequencing. The sequences of the two insertion/ deletion polymorphisms, hHAVcr-1*allele2 and hHAVcr-1*allele3, are shown in Figure 1 , and both are located in 
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The results of transmission disequilibrium tests (TDTs) of asthmatic families are shown in Table 1 . None of the hHAVcr-1 alleles were transmitted preferentially to asthma-affected children (P40.1). Mean log[total serum lgE] levels of parents with allele1/allele1, allele1/allele2, and allele1/allele3 genotypes were 2.05, 2.05, and 1.98, respectively, and significant association was not observed between the groups (P40.1). In quantitative TDT analysis, 12 no association was observed between log[total lgE] and either allele of the hHAVcr-1 polymorphism (P40.1).
The statistical power of TDT 13 for À1634G, À1547C, À1453A, hHAVcr-1*allele2, hHAVcr-1*allele3, and IVS8+9A was 0.95, 0.93, 0.93, 0.90, 0.50, and 0.88, respectively, at an alpha level of 0.05, if the relative risk for asthma in those persons carrying a putative risk allele is 2 compared to that in persons without the allele. Since TIM3 mutations are rare, we did not genotype TIM3 mutations in our Japanese study population.
McIntire et al 10 examined congenic mice that differed only at the segment homologous to human 5q23-35 and identified a region related to the development of AHR and T-cell production of interleukin (IL)-4 and IL-13.
10
The region includes KIAA0171, Adam19, SOX30, Pir121, CRSP9, ITK, and TIM1. They did not identify coding polymorphisms in CRSP9 or ITK, but they found functional coding polymorphisms in TIM1 and T1M3. Mouse TIM1 encodes a 305 amino-acid membrane protein that has 42% identity with hHAVcr-1. 10 We found seven polymorphisms including two insertion/deletion polymorphisms in the coding region of hHAVcr-1, but neither was associated with the development of asthma in Japanese asthmatic families that showed strong evidence for linkage of atopic asthma to this region. 9 Therefore, our data suggest that the 5q33 region in humans and the homologous region in mice contain genes responsible for development of asthma, but that genes other than hHAVcr-l are likely to contribute to the development of asthma in the Japanese. It should be kept in mind, however, that the hHAVcr-1*allele3 is rare, with a frequency of only 3%. Therefore, only the possibility that the hHAVcr-1*allele3 polymorphism plays a substantial role in the development of the atopic phenotypes examined herein can be excluded.
TIM3 is a recently identified T-cell transmembrane protein expressed on differentiated Th-1 cells.
14 Mouse TIM3 variants are also associated with airway hvperresponsiveness and T-cell production of IL-4 and 1L-13. 10 We screened for mutations in human TIM3 in Japanese asthmatics, but no common polymorphisms were identified.
Inverse association between antibodies to hepatitis A virus and atopy has been reported in Italians. 15, 16 A total of 443 (26.7%) of 1659 military students recruited in 1990 and 1991 for an epidemiologic study were positive for hepatitis A antibody; seropositivities to common airborne allergens and the prevalence of atopic diseases such as asthma were less frequent in hepatitis A seropositive subjects than in seronegative subjects. 15, 16 Even though a relation between atopy and hepatitis A antibody has not been reported in Japan, prevalence of hepatitis A seropositivity in healthy Japanese subjects was shown to be low in young subjects. Seropositivity was 0% (0/176) in 10to19-year olds, 1.2% (2/161) in 20 to 29-year olds, 3.9% (6/155) in 30 to 39-year olds, and 52.6% (60/114) in 40 to 49-year olds. 17 These data suggest the low exposure to hepatitis A virus in the young generation in Japan. Therefore, the possibility remains that hHAVcr-l polymorphisms might be associated with the development of atopic diseases in populations with a high prevalence of hepatitis A infection if hHAVcr-1 polymorphisms alter the susceptibility to hepatitis A infection.
hHAVcr-1 is 79% identical to HAVcr-1 of African green monkeys. 18 The insertion/deletion polymorphisms identified in the present study are located in the threonine-, serine-, and proline-rich region of the extracellular domain (Figure 1 ). Therefore, it is possible that these mutations alter susceptibility to hepatitis A infection.
Although we did not observe associations between the hHAVcr-1 polymorphisms and atopic asthma in the Japanese asthmatic families, these polymorphisms may be related to susceptibility to hepatitis A infection. Further studies of different populations are needed to elucidate the roles of hHAVcr-1 polymorphisms in the development of atopic and infectious diseases. Genotypes were determined by direct sequencing and PCR-restriction fragment length polymorphism method. Primer pair 5 0 -GTGCCTGGCAAGAAATGAAT-3 0 and 5 0 -TGTTTTGTATGGCAGCGTTT-3 0 was used to amplify the À1634A/G, À1606A/C, À1547G/C, and À1453G/A polymorphisms. Primer pair 5 0 -AGGGTACAGTTCCAGCCTGA-3 0 and 5 0 -CATCCGTGGTCCAGCTATTT-3 0 was used to amplify the insertion/deletion polymorphisms in exon 4. PCR products were subjected to direct sequencing. Primer pair 5 0 -TTTTCTCTTCAACTCCTCTCTCC-3 0 and 5 0 -GCCACAACTCCAGGGAAATA-3 0 was used to amplify IVS8+9G/A, and PCR products were digested with TaqI to type the IVS8+9G/A polymorphism, which was assessed as loss of a Taq I site (G allele, 81 bp, 183 bp; A allele, 264 bp). Digested PCR fragments were separated by electrophoresis on agarose gels and visualized by ethidium bromide staining and ultraviolet transillumination. Allelic TDTs were done with the GeneHunter program. 
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